查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1618255

单采市场洞察·竞争环境·市场预测 (～2030年)

Apheresis - Market Insights, Competitive Landscape, and Market Forecast - 2030
出版日期: | 出版商: DelveInsight | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

单采市场规模预计将从 2023 年的 22.3066 亿美元增长到 2030 年的 36.7155 亿美元，预测期内复合年增长率为 8.75%。

免疫性血小板减少症(ITP) 和血友病等慢性病患病率的增加、产品开发活动的增加以及生物製药公司对原料血浆的需求增加将推动预测期内的市场增长，预计这将有助于整体成长。

单采术：市场动态

根据 2022 年国家罕见疾病组织的数据，免疫性血小板减少症 (ITP) 可以影响所有年龄层的人，从 3 个月大的婴儿到 100 岁以上的老年人。大约 40% 被诊断出患有 ITP 的患者是 10 岁以下的儿童。在全球范围内，估计有超过 20 万人受到这种疾病的影响。

根据世界血友病联合会（2022 年）的报告，全球每年约有 20,000 人患有血友病，其中约 7,000 人被列为严重血友病。血友病患者人数为233,577人，其中185,318人患有血友病A，37,998人患有血友病B。

免疫性血小板减少症 (ITP) 和血友病等慢性血液疾病的盛行率不断上升，推动了对先进治疗方案（包括血浆分离术）的需求。单采术是一种有价值的治疗方法，可针对性地去除或更换血液成分，以控制出血併发症和免疫功能障碍并改善患者的预后。此外，全球在获得凝血因子方面存在差异，表明需要替代疗法，例如血浆分离术，从而进一步扩大市场潜力。

按地区划分，北美地区估计占收入的很大一部分。这被认为是由于多种因素造成的，包括癌症和格林巴利症候群 (GBS) 患者数量的增加、持续的产品开发策略以及治疗能力和效率的提高。

本报告提供全球单采的市场调查，彙整市场概要，市场影响因素及市场机会分析，法律制度，市场规模的转变·预测，各种区分·地区/各主要国家的详细分析，竞争情形，主要企业简介等资讯。

目录

第1章 单采市场报告:简介

  • 调查范围
  • 市场分类
  • 市场估计

第2章 单采市场:摘要整理

  • 市场概要

第3章 竞争情形

第4章 法规分析

  • 美国
  • 欧洲
  • 日本
  • 中国

第5章 单采市场:主要要素分析

  • 推动市场要素
    • 慢性病盛行率不断上升
    • 全球产品开发活动增加
    • 生药厂对原料血浆的需求不断增加
  • 市场限制与课题
    • 单采过程成本高
    • 与单采过程相关的风险
  • 市场机会
    • 专为儿童设计的新型单采疗法的创新和研发激增
    • 脂蛋白去除疗法的成本降低与普及

第6章 单采市场:波特的五力分析

第7章 单采市场评估

  • 各产品类型
    • 单采设备
    • 抛弃式
  • 各技术
    • 离心分离
    • 薄膜过滤
  • 治疗
    • 白血球消除疗法
    • 血浆替换
    • 血小板成分采取
    • 红血球消除疗法
    • 其他
  • 各用途
    • 肾臟疾病
    • 血液疾病
    • 神经疾病
    • 自体免疫疾病
  • 各地区
    • 北美
    • 欧洲
    • 亚太地区
    • 其他地区

第8章 单采市场:企业·产品简介

  • B. Braun Melsungen AG
  • Asahi Kasei Corporation
  • Fresenius Kabi AG
  • Haemonetics Corporation
  • Terumo Corporation
  • Baxter
  • Kaneka Corporation
  • Sumitomo Bakelite Company Limited
  • Medica SPA
  • Nikkiso Co., Ltd.
  • Cerus Corporation
  • Miltenyi Biotec B.V. & Co. KG
  • Haier Inc.
  • Otsuka Holdings

第9章 KOL的见解

第10章 计划的方法

第11章 关于DelveInsight

第12章 免责声明·联络方式

Product Code: DIMDCL0364

Apheresis Market by Product Type (Apheresis machines and Disposables), Technology (Centrifugation and Membrane filtration), Procedure (Leukapheresis, Plasmapheresis, Plateletpheresis, Erythrocytapheresis, and Others), Application (Renal Disorders, Hematological Disorders, Neurological Disorders, Autoimmune Disorders, and Others), Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to advance at a substantial CAGR forecast till 2030 owing to the increasing prevalence of chronic disorders and increasing product developmental activities around the world

The apheresis market was valued at USD 2,230.66 million in 2023 and is estimated to grow at a CAGR of 8.75% during the forecast period from 2024 to 2030 to reach USD 3,671.55 million by 2030. The market is experiencing significant growth due to the increasing prevalence of different types of chronic disorders like immune thrombocytopenia (ITP) and hemophilia among the population, rising product developmental activities, and rising demand for source plasma from biopharmaceutical companies acting as major factors contributing to the overall growth of the apheresis market during the forecast period from 2024 to 2030.

Apheresis Market Dynamics:

The National Organization for Rare Disorders in 2022, stated that immune thrombocytopenia (ITP) can affect individuals of all ages, ranging from as young as 3 months to over 100 years old. Approximately 40% of those diagnosed with ITP are children under the age of 10. Globally, it is estimated that more than 200,000 people are affected by this condition.

According to the World Federation of Haemophilia (2022) reports, approximately 20,000 people with hemophilia are born each year worldwide, with about 7,000 of these cases being classified as severe. In addition to this, the source further stated that there are 233,577 individuals with hemophilia, comprising 185,318 with Hemophilia A and 37,998 with Hemophilia B.

The rising prevalence of chronic hematological disorders like immune thrombocytopenia (ITP) and hemophilia is driving the demand for advanced treatment options, including apheresis. Apheresis offers targeted removal or replacement of blood components, making it a valuable therapy for managing bleeding complications, immune dysfunction, and improving patient outcomes. Additionally, the global disparities in access to clotting factors highlight the need for alternative therapeutic modalities like apheresis, further expanding its market potential.

Various product development activities by key market players will further boost the market for the same. For instance, in May 2021, Baxter International Inc. announced the global launch of PrisMax 2, the latest version of the company's next-generation platform. PrisMax 2 is designed for therapeutic plasma exchange therapy and other organ support therapies while providing hospitals the flexibility to meet the unique demands of the intensive care unit (ICU).

Hence, the interplay of all the above-mentioned factors is expected to drive the apheresis market during the given forecast period from 2024 to 2030.

However, the high cost involved in the apheresis process, risks associated with the apheresis process, and others may restrict the market growth for the apheresis market.

Apheresis Market Segment Analysis:

Apheresis Market by Product Type (Apheresis machines and Disposables), Technology (Centrifugation and Membrane filtration), Procedure (Leukapheresis, Plasmapheresis, Plateletpheresis, Erythrocytapheresis, and Others), Application (Renal Disorders, Hematological Disorders, Neurological Disorders, Autoimmune Disorders, and Others), Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the product type segment of the apheresis market, the disposables category is expected to have a significant revenue share in the year 2023. This can be attributed to the increased consumption of disposables in the process of apheresis.

The disposables present in apheresis machines are manufactured and designed exclusively for one-time use, to ensure contamination-free transfer of blood components and maintain sterile conditions. Disposables form a key component for any apheresis system to deliver quality treatment, because of which all the key market players ensure a strong disposable kit profile for their apheresis systems. The Plasmat Futura Kit from B. Braun Melsungen AG, LIFE 21(R) and LIFE 18(TM) apheresis unit's disposables from Miltenyi Biotec, the disposable TPE 2000 Set for PRISMAFLEX System from Baxter are some of the examples of quality disposables manufactured by key companies to build and flourish their market for apheresis.

Therefore, the widespread uses and various advantages of the disposables category that enhance performance and usability, solidify a significant impact on the growth of the overall apheresis market during the forecast period from 2024 to 2030.

North America is expected to dominate the overall apheresis market:

Among all the regions, North America is estimated to hold a significant revenue share in the apheresis market. This can be attributed to several factors such as rising cancer cases and Guillain-Barre Syndrome (GBS), continuous product developmental strategies by regulatory bodies, that offer improved treatment features and efficiency, that act as key factors contributing to the growth of the apheresis market in the North America region during the forecast period from 2024 to 2030.

As per figures directed by the Globocan 2024, it indicated that in the year 2022 Leukemia affected 63,144 people in the US, whereas in Canada leukemia affected about 8,503 people. The same source also mentioned that by the year 2045, leukemia will afflict about 101 thousand people in the North America region. As leukemia cases rise, apheresis is increasingly utilized for managing complications like hyperleukocytosis and for collecting stem cells for transplants and thereby the market for the same is increased.

According to data from the Centers for Disease Control and Prevention (2023), it stated that Guillain-Barre Syndrome (GBS) is a rare disorder in which the body's immune system mistakenly attacks the peripheral nerves. This damage to the nerves leads to muscle weakness and, in some cases, paralysis. The exact cause of GBS is not fully understood, but it frequently occurs following an infection with a virus or bacteria. In the United States, an estimated 3,000 to 6,000 people develop GBS each year. Apheresis plays a critical role in treating autoimmune disorders like Guillain-Barre Syndrome by removing harmful antibodies. Thus the rising clinical reliance highlights the expanding market for apheresis systems and services.

Various product developmental strategies such as clearances by regulatory authorities in the region play a major role in pushing forward the revenue shares of apheresis. For example, in August 2023, Terumo Blood and Cell Technologies (Terumo BCT) announced the U.S. Food and Drug Administration (FDA) clearance of the Reveos Automated Whole Blood Processing System, the first whole blood automation device available in the U.S. that processes whole blood into platelets and other components in a single centrifugation cycle.

Moreover, product launches by key market players in the region are further expected to propel the growth of the North America apheresis market.

Therefore, the interplay of all the factors mentioned above would provide a conducive growth environment for the North America region in the apheresis market during the forecast period from 2024 to 2030.

Apheresis Market key players:

Some of the key market players operating in the apheresis market include B. Braun Melsungen AG, Asahi Kasei Corporation, Fresenius Kabi AG, Haemonetics Corporation, Terumo Corporation, Baxter, Kaneka Corporation, Sumitomo Bakelite Company Limited, Medica SPA, Nikkiso Co., Ltd., Cerus Corporation, Miltenyi Biotec B.V. & Co. KG, Haier Inc., Otsuka Holdings, and others.

Recent Developmental Activities in the Apheresis Market:

  • In September 2023, Sanguine Biosciences (Sanguine), a leader in connecting patients with biomedical researchers to accelerate precision medicine R&D, announced the opening of a blood donor center in Los Angeles. The center specialized in collecting concentrated white blood cell biospecimens through apheresis.
  • In June 2022, Terumo Blood and Cell Technologies, a medical technology company specializing in products, software, and services for blood component collection, therapeutic apheresis, and cellular technologies, announced that NHS England selected the automated red blood cell exchange (RBCX) procedure, performed using the company's Spectra Optia(R) Apheresis System, through the NHS MedTech Funding Mandate (MTFM) for treating sickle cell disease.

Key takeaways from the Apheresis market report study

  • Market size analysis for current apheresis market size (2023), and market forecast for 6 years (2024 to 2030)
  • Top key product/services developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years
  • Key companies dominating the apheresis market
  • Various opportunities available for the other competitors in the apheresis market space
  • What are the top-performing segments in 2023? How these segments will perform in 2030?
  • Which are the top-performing regions and countries in the current apheresis market scenario?
  • Which are the regions and countries where companies should have concentrated on opportunities for apheresis market growth in the coming future?

Target audience who can be benefited from this Apheresis market report study

  • Apheresis device providers
  • Research organizations and consulting companies
  • Apheresis-related organizations, associations, forums, and other alliances
  • Government and corporate offices
  • Start-up companies, venture capitalists, and private equity firms
  • Distributors and traders dealing in apheresis
  • Various end-users who want to know more about the apheresis market and the latest developments in the apheresis market

Frequently Asked Questions for the Apheresis Market:

1. What are apheresis?

  • The apheresis is a medical technology used to separate various constituents of the blood, in which the remaining components of the blood are returned to the patient after extraction of the desired component (viz. erythrocytes, leukocytes, plasma, platelets etc.).

2. What is the market for apheresis?

  • The apheresis market was valued at USD 2,230.66 million in 2023 and is estimated to grow at a CAGR of 8.75% during the forecast period from 2024 to 2030 to reach USD 3,671.55 million by 2030.

3. What are the drivers for the apheresis market?

  • The market is experiencing significant growth due to the increasing prevalence of different types of chronic disorders like immune thrombocytopenia (ITP) and hemophilia among the population, rising product developmental activities, and rising demand for source plasma from biopharmaceutical companies that are acting as major factors contributing to the overall growth of the apheresis market during the forecast period from 2024 to 2030.

4. Who are the key players operating in the apheresis market?

  • Some of the major market players operating in the apheresis market include B. Braun Melsungen AG, Asahi Kasei Corporation, Fresenius Kabi AG, Haemonetics Corporation, Terumo Corporation, Baxter, Kaneka Corporation, Sumitomo Bakelite Company Limited, Medica SPA, Nikkiso Co., Ltd., Cerus Corporation, Miltenyi Biotec B.V. & Co. KG, Haier Inc., Otsuka Holdings, and others.

5. Which region has the highest share in the apheresis market?

  • Among all the regions, North America is estimated to hold a significant revenue share in the apheresis market. This can be attributed to several factors such as rising cancer cases and Guillain-Barre Syndrome (GBS), continuous product developmental strategies by regulatory bodies, that offer improved treatment features and efficiency, which are the major key factors that contribute to the growth of the apheresis market in the North America region during the forecast period from 2024 to 2030.

Table of Contents

1. Apheresis Market Report Introduction

  • 1.1. Scope of the Study
  • 1.2. Market Segmentation
  • 1.3. Market Assumption

2. Apheresis Market Executive Summary

  • 2.1. Market at Glance

3. Competitive Landscape

4. Regulatory Analysis

  • 4.1. The United States
  • 4.2. Europe
  • 4.3. Japan
  • 4.4. China

5. Apheresis Market Key Factors Analysis

  • 5.1. Apheresis Market Drivers
    • 5.1.1. Increasing prevalence of chronic disorders
    • 5.1.2. Increasing product developmental activities around the world
    • 5.1.3. Rising demand for source plasma from biopharmaceutical companies
  • 5.2. Apheresis Market Restraints and Challenges
    • 5.2.1. High cost involved in the apheresis process
    • 5.2.2. Risks associated with the apheresis process
  • 5.3. Apheresis Market Opportunities
    • 5.3.1. Surge in innovation and R&D for new apheresis treatment methods specially designed for children
    • 5.3.2. Reduction in the cost of lipoprotein apheresis and widespread availability of the therapy

6. Apheresis Market Porter's Five Forces Analysis

  • 6.1. Bargaining Power of Suppliers
  • 6.2. Bargaining Power of Consumers
  • 6.3. Threat of New Entrants
  • 6.4. Threat of Substitutes
  • 6.5. Competitive Rivalry

7. Apheresis Market Assessment

  • 7.1. By Product Type
    • 7.1.1. Apheresis machines
    • 7.1.2. Disposables
  • 7.2. By Technology
    • 7.2.1. Centrifugation
    • 7.2.2. Membrane filtration
  • 7.3. By Procedure
    • 7.3.1. Leukapheresis
    • 7.3.2. Plasmapheresis
    • 7.3.3. Plateletpheresis
    • 7.3.4. Erythrocytapheresis
    • 7.3.5. Others
  • 7.4. By Application
    • 7.4.1. Renal Disorders
    • 7.4.2. Hematological Disorders
    • 7.4.3. Neurological Disorders
    • 7.4.4. Autoimmune Disorders
    • 7.4.5. Others
  • 7.5. By Geography
    • 7.5.1. North America
      • 7.5.1.1. United States Apheresis Market Size in USD million (2021-2030)
      • 7.5.1.2. Canada Apheresis Market Size in USD million (2021-2030)
      • 7.5.1.3. Mexico Apheresis Market Size in USD million (2021-2030)
    • 7.5.2. Europe
      • 7.5.2.1. France Apheresis Market Size in USD million (2021-2030)
      • 7.5.2.2. Germany Apheresis Market Size in USD million (2021-2030)
      • 7.5.2.3. United Kingdom Apheresis Market Size in USD million (2021-2030)
      • 7.5.2.4. Italy Apheresis market size in USD million (2021-2030)
      • 7.5.2.5. Spain Apheresis Market Size in USD million (2021-2030)
      • 7.5.2.6. Rest of Europe Apheresis Market Size in USD million (2021-2030)
    • 7.5.3. Asia-Pacific
      • 7.5.3.1. China Apheresis Market Size in USD million (2021-2030)
      • 7.5.3.2. Japan Apheresis Market Size in USD million (2021-2030)
      • 7.5.3.3. India Apheresis Market Size in USD million (2021-2030)
      • 7.5.3.4. Australia Apheresis Market Size in USD million (2021-2030)
      • 7.5.3.5. South Korea Apheresis Market Size in USD million (2021-2030)
      • 7.5.3.6. Rest of Asia-Pacific Apheresis Market Size in USD million (2021-2030)
    • 7.5.4. Rest of the World (RoW)
      • 7.5.4.1. Middle East Apheresis Market Size in USD million (2021-2030)
      • 7.5.4.2. Africa Apheresis Market Size in USD million (2021-2030)
      • 7.5.4.3. South America Apheresis Market Size in USD million (2021-2030)

8. Apheresis Market Company and Product Profiles

  • 8.1. B. Braun Melsungen AG
    • 8.1.1. Company Overview
    • 8.1.2. Company Snapshot
    • 8.1.3. Financial Overview
    • 8.1.4. Product Listing
    • 8.1.5. Entropy
  • 8.2. Asahi Kasei Corporation
    • 8.2.1. Company Overview
    • 8.2.2. Company Snapshot
    • 8.2.3. Financial Overview
    • 8.2.4. Product Listing
    • 8.2.5. Entropy
  • 8.3. Fresenius Kabi AG
    • 8.3.1. Company Overview
    • 8.3.2. Company Snapshot
    • 8.3.3. Financial Overview
    • 8.3.4. Product Listing
    • 8.3.5. Entropy
  • 8.4. Haemonetics Corporation
    • 8.4.1. Company Overview
    • 8.4.2. Company Snapshot
    • 8.4.3. Financial Overview
    • 8.4.4. Product Listing
    • 8.4.5. Entropy
  • 8.5. Terumo Corporation
    • 8.5.1. Company Overview
    • 8.5.2. Company Snapshot
    • 8.5.3. Financial Overview
    • 8.5.4. Product Listing
    • 8.5.5. Entropy
  • 8.6. Baxter
    • 8.6.1. Company Overview
    • 8.6.2. Company Snapshot
    • 8.6.3. Financial Overview
    • 8.6.4. Product Listing
    • 8.6.5. Entropy
  • 8.7. Kaneka Corporation
    • 8.7.1. Company Overview
    • 8.7.2. Company Snapshot
    • 8.7.3. Financial Overview
    • 8.7.4. Product Listing
    • 8.7.5. Entropy
  • 8.8. Sumitomo Bakelite Company Limited
    • 8.8.1. Company Overview
    • 8.8.2. Company Snapshot
    • 8.8.3. Financial Overview
    • 8.8.4. Product Listing
    • 8.8.5. Entropy
  • 8.9. Medica SPA
    • 8.9.1. Company Overview
    • 8.9.2. Company Snapshot
    • 8.9.3. Financial Overview
    • 8.9.4. Product Listing
    • 8.9.5. Entropy
  • 8.10. Nikkiso Co., Ltd.
    • 8.10.1. Company Overview
    • 8.10.2. Company Snapshot
    • 8.10.3. Financial Overview
    • 8.10.4. Product Listing
    • 8.10.5. Entropy
  • 8.11. Cerus Corporation
    • 8.11.1. Company Overview
    • 8.11.2. Company Snapshot
    • 8.11.3. Financial Overview
    • 8.11.4. Product Listing
    • 8.11.5. Entropy
  • 8.12. Miltenyi Biotec B.V. & Co. KG
    • 8.12.1. Company Overview
    • 8.12.2. Company Snapshot
    • 8.12.3. Financial Overview
    • 8.12.4. Product Listing
    • 8.12.5. Entropy
  • 8.13. Haier Inc.
    • 8.13.1. Company Overview
    • 8.13.2. Company Snapshot
    • 8.13.3. Financial Overview
    • 8.13.4. Product Listing
    • 8.13.5. Entropy
  • 8.14. Otsuka Holdings
    • 8.14.1. Company Overview
    • 8.14.2. Company Snapshot
    • 8.14.3. Financial Overview
    • 8.14.4. Product Listing
    • 8.14.5. Entropy

9. KOL Views

10. Project Approach

11. About DelveInsight

12. Disclaimer & Contact Us

List of Tables

  • Table 1: Competitive Analysis
  • Table 2: Apheresis Market in Global (2021-2030)
  • Table 3: Apheresis Market in Global by Product Type (2021-2030)
  • Table 4: Apheresis Market in Global by Technology (2021-2030)
  • Table 5: Apheresis Market in Global by Procedure (2021-2030)
  • Table 6: Apheresis Market in Global by Application (2021-2030)
  • Table 7: Apheresis Market in Global by Geography (2021-2030)
  • Table 8: Apheresis Market in North America (2021-2030)
  • Table 9: Apheresis Market in the United States (2021-2030)
  • Table 10: Apheresis Market in Canada (2021-2030)
  • Table 11: Apheresis Market in Mexico (2021-2030)
  • Table 12: Apheresis Market in Europe (2021-2030)
  • Table 13: Apheresis Market in France (2021-2030)
  • Table 14: Apheresis Market in Germany (2021-2030)
  • Table 15: Apheresis Market in United Kingdom (2021-2030)
  • Table 16: Apheresis Market in Italy (2021-2030)
  • Table 17: Apheresis Market in Spain (2021-2030)
  • Table 18: Apheresis Market in the Rest of Europe (2021-2030)
  • Table 19: Apheresis Market in Asia-Pacific (2021-2030)
  • Table 20: Apheresis Market in China (2021-2030)
  • Table 21: Apheresis Market in Japan (2021-2030)
  • Table 22: Apheresis Market in India (2021-2030)
  • Table 23: Apheresis Market in Australia (2021-2030)
  • Table 24: Apheresis Market in South Korea (2021-2030)
  • Table 25: Apheresis Market in Rest of Asia-Pacific (2021-2030)
  • Table 26: Apheresis Market in the Rest of the World (2021-2030)
  • Table 27: Apheresis Market in the Middle East (2021-2030)
  • Table 28: Apheresis Market in Africa (2021-2030)
  • Table 29: Apheresis Market in South America (2021-2030)

List of Figures

  • Figure 1: Competitive Analysis
  • Figure 2: Apheresis Market in Global (2021-2030)
  • Figure 3: Apheresis Market in Global by Product Type (2021-2030)
  • Figure 4: Apheresis Market in Global by Technology (2021-2030)
  • Figure 5: Apheresis Market in Global by Procedure (2021-2030)
  • Figure 6: Apheresis Market in Global by Application (2021-2030)
  • Figure 7: Apheresis Market in Global by Geography (2021-2030)
  • Figure 8: Apheresis Market in North America (2021-2030)
  • Figure 9: Apheresis Market in the United States (2021-2030)
  • Figure 10: Apheresis Market in Canada (2021-2030)
  • Figure 11: Apheresis Market in Mexico (2021-2030)
  • Figure 12: Apheresis Market in Europe (2021-2030)
  • Figure 13: Apheresis Market in France (2021-2030)
  • Figure 14: Apheresis Market in Germany (2021-2030)
  • Figure 15: Apheresis Market in United Kingdom (2021-2030)
  • Figure 16: Apheresis Market in Italy (2021-2030)
  • Figure 17: Apheresis Market in Spain (2021-2030)
  • Figure 18: Apheresis Market in the Rest of Europe (2021-2030)
  • Figure 19: Apheresis Market in Asia-Pacific (2021-2030)
  • Figure 20: Apheresis Market in China (2021-2030)
  • Figure 21: Apheresis Market in Japan (2021-2030)
  • Figure 22: Apheresis Market in India (2021-2030)
  • Figure 23: Apheresis Market in Australia (2021-2030)
  • Figure 24: Apheresis Market in South Korea (2021-2030)
  • Figure 25: Apheresis Market in Rest of Asia-Pacific (2021-2030)
  • Figure 26: Apheresis Market in the Rest of the World (2021-2030)
  • Figure 27: Apheresis Market in the Middle East (2021-2030)
  • Figure 28: Apheresis Market in Africa (2021-2030)
  • Figure 29: Apheresis Market in South America (2021-2030)
  • Figure 30: Market Drivers
  • Figure 31: Market Barriers
  • Figure 32: Marker Opportunities
  • Figure 33: PORTER'S Five Force Analysis